Skip to main content
OpenTrials
Completed

NCT Number: NCT02443025

Teens Against Tobacco Use: A Model for Universal Tobacco Prevention and Youth Advocacy

This study evaluates the efficacy of Teens Against Tobacco Use anti-tobacco presentations on tobacco use susceptibility in 4th-8th grade. Classrooms are randomly assigned to either receive a series of two presentations or wait listed to receive them later in the school year.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

The University of Texas Health Science Center at Houston, School of Public Health, El Paso Regional Campus

El Paso, Texas, 79902, United States

About this study

The investigators will collaborate with Austin High School, Wiggs Middle School, and Guillen Middle School of the El Paso Independent School District to implement smoke free youth coalitions as an after school activity. The coalitions will follow the Teens Against Tobacco Use (TATU) model developed by the American Lung Association, the American Cancer Society, and the American Heart Association. Participating youth will be trained to develop and deliver anti-tobacco presentations to younger students. Each school will have a separate youth coalition operating under the guidance of an adult coordinator. High school youth will present to middle school classes, whereas middle school youth will present to 4th and 5th graders.

To evaluate the efficacy of the smoke-free presentations, the investigators will first match pairs of classrooms willing to have a presentation and then randomly assign one classroom in each pair to either receive the presentation first (intervention condition) or later in the school year (control condition). Following a presentation to a classroom in the intervention condition, investigators will administer a brief survey about tobacco to students in both the intervention class and its matched control class, who have not yet received a presentation. Analyses will compare intervention and control classrooms on smoking susceptibility, perceptions of harm from tobacco use, tobacco industry perceptions, and social norms on tobacco use.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 4th to 8th grade student
  • Classroom must be willing to be randomly assigned to either receive presentations earlier in the school year or late in the school year

Exclusion criteria

  • Classes in participating schools that are not in the 4th to 8th grade
  • Students not able to read English or Spanish

Treatment and study plan

Teens Against Tobacco Use

Behavioral

Teens Against Tobacco Use teen teachers develop and then deliver anti-tobacco presentations to the target population of younger students.

Primary outcomes

  1. Standardized Tobacco Susceptibility as assessed by 12 likert scale items drawn primarily from the global youth tobacco survey

    Time frame: within 24 hours of receiving presentation

    Tobacco susceptibility captures the likelihood of using tobacco in the future. It is a continuous variable that will be standardized, so outcomes will represent standard deviation unit differences in tobacco susceptibility.

Sponsors and collaborators

Lead sponsor

The University of Texas Health Science Center, Houston

Other

Collaborators

  • Paso del Norte Health Foundation

Registry information

Acronym: TATU

Important dates

Study start
2014
Primary completion
2015
Study completion
2015
First posted
May 13, 2015
Registry last updated
Oct 14, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.